Katherine V Gates1,2, Qi Xing2, Leigh G Griffiths2. 1. Department of Veterinary Medicine and Epidemiology, University of California, Davis, One Shields Avenue, Davis, CA, 95616, USA. 2. Department of Cardiovascular Diseases, Mayo Clinic, 200 First Street SW, Rochester, MN, 55905, USA.
Abstract
PURPOSE: This case-control retrospective discovery study is to identify antigenic bovine pericardium (BP) proteins that stimulate graft-specific humoral immune response in patients implanted with glutaraldehyde fixed bovine pericardial (GFBP) heart valves. EXPERIMENTAL DESIGN: Banked serum is collected from age- and sex-matched patients who received either a GFBP or mechanical heart valve replacement. Serum IgG is isolated and used to generate poly-polyclonal antibody affinity chromatography columns from each patient. Native and deglycosylated BP protein extracts are separately added to individual patient affinity chromatography columns, with unbound proteins washed through the column. Proteins captured in the affinity chromatography columns are submitted for proteomic identification. Differences between GFBP and mechanical heart valve replacement recipients are analyzed with Gaussian linearized modeling. RESULTS: Carbohydrate antigens overwhelm protein capture in the column, requiring BP protein deglycosylation prior to affinity chromatography. Nineteen BP protein antigens, which stimulated graft-specific IgG production, are identified in patients who received GFBP valve replacements. Identified antigens are significantly over-represented for calcium-binding proteins. CONCLUSIONS AND CLINICAL RELEVANCE: Patients implanted with GFBP valves develop a graft-specific humoral immune response toward BP protein antigens, with 19 specific antigens identified in this work. The molecular functions of over-represented antigens, specifically calcium-binding proteins, may aid in understanding the underlying factors that contribute to structural valve deterioration.
PURPOSE: This case-control retrospective discovery study is to identify antigenic bovine pericardium (BP) proteins that stimulate graft-specific humoral immune response in patients implanted with glutaraldehyde fixed bovine pericardial (GFBP) heart valves. EXPERIMENTAL DESIGN: Banked serum is collected from age- and sex-matched patients who received either a GFBP or mechanical heart valve replacement. Serum IgG is isolated and used to generate poly-polyclonal antibody affinity chromatography columns from each patient. Native and deglycosylated BP protein extracts are separately added to individual patient affinity chromatography columns, with unbound proteins washed through the column. Proteins captured in the affinity chromatography columns are submitted for proteomic identification. Differences between GFBP and mechanical heart valve replacement recipients are analyzed with Gaussian linearized modeling. RESULTS:Carbohydrate antigens overwhelm protein capture in the column, requiring BP protein deglycosylation prior to affinity chromatography. Nineteen BP protein antigens, which stimulated graft-specific IgG production, are identified in patients who received GFBP valve replacements. Identified antigens are significantly over-represented for calcium-binding proteins. CONCLUSIONS AND CLINICAL RELEVANCE: Patients implanted with GFBP valves develop a graft-specific humoral immune response toward BP protein antigens, with 19 specific antigens identified in this work. The molecular functions of over-represented antigens, specifically calcium-binding proteins, may aid in understanding the underlying factors that contribute to structural valve deterioration.
Authors: D K Strickland; J D Ashcom; S Williams; F Battey; E Behre; K McTigue; J F Battey; W S Argraves Journal: J Biol Chem Date: 1991-07-15 Impact factor: 5.157
Authors: Geir Helgeland; Axel Petzold; Steven Paul Luckman; Nils Erik Gilhus; Gordon T Plant; Fredrik Robert Romi Journal: Eur Neurol Date: 2011-01-06 Impact factor: 1.710
Authors: B C Valdez; D Henning; R K Busch; K Woods; H Flores-Rozas; J Hurwitz; L Perlaky; H Busch Journal: Nucleic Acids Res Date: 1996-04-01 Impact factor: 16.971
Authors: Joanna E Parkes; Simon Rothwell; Philip J Day; Neil J McHugh; Zoë E Betteridge; Robert G Cooper; William E Ollier; Hector Chinoy; Janine A Lamb Journal: Arthritis Res Ther Date: 2016-07-07 Impact factor: 5.156
Authors: Alexander E Kostyunin; Arseniy E Yuzhalin; Maria A Rezvova; Evgeniy A Ovcharenko; Tatiana V Glushkova; Anton G Kutikhin Journal: J Am Heart Assoc Date: 2020-09-21 Impact factor: 5.501